|

|
Li Zhang
Ph.D.
|
| Academic Title:
Associate Professor |
| Primary Appointment:
Physiology |
| Secondary Appointments:
Surgery |
|
lizhang@som.umaryland.edu |
| Location:
UMB BioPark Building 1,
216 |
| Phone:
410-706-8040 |
| Fax:
410-706-8121 |
|
Personal History
I received my PhD in Biochemistry and Molecular Biology and also had my postdoctoral training at the University of Notre Dame, Notre Dame, Indiana. I joined the faculty of the University of Maryland, School of Medicine in 2004 as an Associate Professor. My research program has been continuously funded and supported by the National Institute of Health and the American Hearst Association. I’m also associated with a training grant from the National Institute of Health.
Research Interests
Stem cells possess the ability to self-renew and to differentiate into multiple tissue types, and thus are ideal source of cells for tissue repair and regeneration. However, successful stem cell-based tissue regeneration depends on our ability to prepare a homogenous stem cell population and to overcome tissue rejection mediated by host immune cells. Thus, our research program comprises two separate projects: one is focused on the roles of mesenchymal stem cells in tissue repair/regeneration and the other is to study the roles of leukocytes in physiological processes, e.g. innate and adaptive immune responses, and in disease development, e.g. atherosclerosis, myocardial infarction, stroke, and osteoporosis.
The long term goal of our research is to better understand the biology of leukocyte integrins, especially the CD18 integrin subfamily, and their roles in both physiological and pathological processes. In particular, our studies will focus on the molecular mechanisms that allow leukocytes to migrate within inflammatory environments (Fig. 1) and to recognize a wide range of physiological and pathological targets via integrin receptors. In addition, based on our recent finding that the CD18 integrin is also expressed by the primitive stromal stem cells and can be used as a cell marker to enrich the stem cell population from total human bone marrow (Fig. 2), we will study the role of CD18 in stromal stem cell proliferation and differentiation, tissue repair and regeneration, as well as its role in the maintenance of a niche microenvironment that is critical to the function of hematopoietic stem cells. The information generated from these studies can be used to assist us in the design of therapeutic reagents that will selectively target the deleterious effects of leukocyte engagement, such as their contributions to pathogenesis of atherosclerosis, arthritis, and other autoimmune diseases, while keeping its host defense functions intact. It can also assist the isolation and enrichment of stromal stem cells for clinical applications.
Our current research interests include:
1. Structure-function studies of the CD18 integrins: the molecular basis of integrin ligand binding and integrin activation.
2. Macrophage trafficking during inflammation and its resolution.
3. Tissue repair and regeneration using stromal stem cells.
4. Identification of an unknown mutation in a human patient that causes defective integrin activation.
Lab Techniques and Equipment
- Various knockout and transgenic mice for evaluating the roles of different proteins and receptors in health and disease.
- Commonly used mouse models in the laboratory
- Balloon angioplasty model
- melanoma tumor growth model
- ectopic bone and bone marrow regeneration
- oral and intravenous immune tolerance model
- Adoptive cell transfer and bone marrow transplantation to study the contribution of a particular protein, surface receptor or cell population in leukocyte functions;
- Laser scanning confocal fluorescence microscopy and FRET to study protein interactions;
- Live cell imaging to study cell migration;
- FACS cell sorting to enrich a particular stem cell population;
- Real time RT-PCR, 2D PAGE, and Mass spectroscopy to study gene expression;
- Protein expression in E.coli, Sf9 insect cells, and yeasts, as well as adherent and suspension eukaryotic cells.
Laboratory Personnel:
- Chunzhang Cao (postdoctoral fellow) Study of macrophage trafficking
- Driss Ehirchiou (postdoctoral fellow) Study of immune regulation
Publications
7. Yu. S., Zhang, L., Jhingan, A., Christiansen, W.T. and Castellino, F.J. (1994) Construction, expression, and properties of a recombinant chimeric human protein C with replacement of its growth factor-like domains by those of human coagulation factor IX. Biochemistry, 33: 823-831.
10. Zhang, L., Muchowski, P.J., Chang, E.R., Soule, H.R., Plow, E.F. and Moyle, M. (1994) Functional interaction between the integrin antagonist NIF and the I domain of CD11b/CD18. Journal of Biological Chemistry, 269: 26419-26423.
17. Ugarova, T.P., Solovjov, D.A., Zhang, L., Loukinov, D.I., Yee, V.C., Medved, L.V., and Plow, E.F. (1998) Identification of a novel recognition sequence for integrin aMb2 within the g-chain of fibrinogen. Journal of Biological Chemistry, 273: 22519-22527.
18. Cierniewski, C.S., Byzowa, T., Papierak, M., Haas, T.A., Niewiarowska, J., Zhang, L., Cieslak, M., and Plow, E.F. (1999) Peptides that mimic natural contact points of fibrinogen for aIIbb3 bind simultaneously to distinct subsites on the receptor and induce differential conformational and microenvironmental changes. Journal of Biological Chemistry, 274: 16923-16932,
21. Simon, D.I., Chen, Z., Xu, H., Li, C.Q., Dong, J., McIntire, L.V., Ballantyne, C.M., Zhang, L., Furman, M.I., Berndt, M.C., and Lopez, J.A. (2000) Platelet glycoprotein ibalpha is a counterreceptor for the leukocyte integrin Mac-1 (CD11b/CD18). Journal of Experimental Medicine 192:193-204.
22. Simon, D.I., Wei, Y., Zhang, L., Rao, N.K., Xu, H., Chen, Z., Liu, Q., Rosenberg, S., and Chapman, H.A. (2000) Identification of a urokinase receptor-integrin interaction site: promiscuous regulator of integrin function. Journal of Biological Chemistry, 275: 10228-10234.
23. Plow, E.F., Haas, T.A., Zhang, L., Loftus, J. and Smith, J.W. (2000) Ligand binding to integrins. Journal of Biological Chemistry 275:21785-21788.
24. Yakubenko, V.P., Solovjov, D.A., Zhang, L., Yee, V.C., Plow, E.F., and Ugarova, T.P. (2001) Identification of the binding site for fibrinogen recogntion peptide g383-395 within the aMI-domain of integrin aMb2. Journal of Biological Chemistry, 276: 13995-14003.
27. Cierniewska-Cieslak, A., Cierniewski, C.S., Blecka, K., Papierak, M., Michalec, L., Zhang,L., Haas, T.A., and Plow, E.F. (2002) Identification and characterization of two cation binding sites in the integrin beta 3 subunit. Journal of Biological Chemistry, 277: 11126-11134.
28. Castellino, F.J., Ploplis, V.A. and Zhang, L. (2002) g-glutamate and b-Hydroxyaspartate in Proteins. Posttranslational Modifications of Proteins: Tools for Functional Proteomics. Edited by C. Kannicht, Chapter 17, page 259-268.
35. Miura, Y., Miura, M., Gronthos, S., Allen, M.R., Cao, C., Uveges, T.E., Bi, Y., Shi, S., and Zhang, L. (2005) Integrin beta2 is a novel surface marker for bone marrow stromal stem cells and plays an important role in osteogenic differentiation in vivo. Proceedings of the National Academy of Sciences 102:14022-14027. see Report on SOM news vol7 number 4, page 2.
36. Cao, C., Lawrence, Li, Y., Von Arnim, C.A., Herz, J., Hyman, B.T., D.A., Strickland, D., and Zhang, L. (2006) Fibrinolytic inhibitor PAI-1 and endocytic receptor LRP coordinate Mac-1-dependent macrophage migration into the lymphatic system. EMBO J 2006, 25:1860–1870.
37. Cao, C., Lawrence, D.A., Li, Y., Von Arnim, C.A., Herz, J., Su, EJ, Makarova, A, Hyman, B.T., D.A., Strickland, D., and Zhang, L. (2006) Endocytic receptor LRP together with tPA and PAI-1 coordinates Mac-1-dependent macrophage migration. The EMBO Journal, 25:1860-1870.
39. Miura, Y., Gao, Z., Miura, M., Seo, B.M., Sonoyama, W., Chen, W., Gronthos, S., Zhang, L., and Shi, S. (2006) Mesenchymal Stem Cell-Organized Bone Marrow Elements: An Alternative Hematopoietic Progenitor Resource. Stem Cells 24:2428-2436.
40. Tang, P., Cao, C., Xu, M., and Zhang, L. (2007) Regulation of integrin activation by cytoskeletal protein Radixin. FEBS Letters 581:1103-1108.
41. Ehirchiou, D., Xiong, Y., Xu, G., Chen, W., Shi, Y., and Zhang, L. (2007) CD11b Facilitates the Development of Peripheral Tolerance by Suppressing Th17 Differentiation. Journal Experimental Medicine 204:1519-24.
42. Bi, Y., Ehirchiou, D., Kilts, T.M., Inkson, C.A., Embree, M.C., Sonoyama, W., Li, L., Leet, A.I., Seo, B., Zhang, L., Shi, S., and Young, M.F. (2007) Identification of tendon stem/progenitor cells and the role of the extracellular matrix in their niche. Nature Medicine. 13:1219-1227.
Faculty members:
Click here to update your contact information and create a profile.
|